Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Closed testing procedures for group sequential clinical trials with multiple endpoints.

D I Tang1, N L Geller

  • 1Statistical Sciences and Epidemiology Division, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, USA. tang@NKI.RFMH.ORG

Biometrics
|April 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trials and epidemiological studies.

Clinical trials (London, England)·2006
Same author

Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.

Circulation·2001
Same author

Neurons in monkey prefrontal cortex that track past or predict future performance.

Science (New York, N.Y.)·2000
Same author

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

Journal of the American College of Cardiology·2000
Same author

Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud.

Controlled clinical trials·2000
Same author

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

Circulation·2000
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces a flexible closed testing approach for clinical trials with multiple endpoints and group sequential monitoring. It enhances existing methods for timely trial stopping and treatment comparisons.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Medical Research Design

Background:

  • Clinical trials often involve multiple endpoints and interim analyses for early stopping (group sequential monitoring).
  • Existing methods for closed testing with group sequential monitoring can be inflexible regarding stopping times.
  • Comparing multiple treatments against a control also presents statistical challenges.

Purpose of the Study:

  • To present a simple, flexible approach for closed testing in clinical trials with multiple endpoints and group sequential monitoring.
  • To describe the earliest and latest possible stopping times within this new framework.
  • To extend the approach to the one-sided multiple comparison problem of several treatments versus a control.

Main Methods:

  • The proposed method utilizes a closed testing procedure adapted for group sequential monitoring.

Related Experiment Videos

  • It defines a flexible stopping rule that accommodates various trial durations.
  • The approach is demonstrated with an example from a respiratory disease clinical trial.

    • Main Results:

    • The developed approach allows for flexible stopping times in clinical trials with multiple endpoints.
    • It offers enhancements to existing statistical methods for group sequential designs.
    • The paradigm is also applicable to multiple treatment-versus-control comparisons.

    Conclusions:

    • The presented closed testing approach provides a flexible and enhanced method for clinical trials with multiple endpoints and group sequential monitoring.
    • This methodology improves decision-making regarding trial stopping and treatment efficacy evaluation.
    • The approach offers a unified framework for complex clinical trial designs.